SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

PayPal Holdings, Inc. engages in the development of technology platforms that enable digital payments and simplifies commerce experiences on behalf of merchants and consumers worldwide. Its solutions include PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The firm also enables consumers to exchange funds with merchants using funding sources, which include bank account, PayPal account balance, PayPal Credit account, credit, and debit card or other stored value products. It operates through United States and Other Countries geographical segments. The company was founded in December 1998 and is headquartered in San Jose, CA.

PayPal Holdings Inc

PayPal is currently the center of intense speculation as the community tracks ongoing acquisition negotiations with a group including Stripe and Advent International. Traders are actively debating potential buyout valuations above recent bids, driving significant volatility and volume in both shares and options as market participants position for a formal deal announcement.

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance is trending as investors react to strong earnings and a surge in institutional ownership, with the community actively speculating on a potential short squeeze as momentum builds. Discussions are heavily focused on the company's long-term commercial trajectory, the significance of upcoming lung cancer trial data, and whether the stock's recent price action signals a broader re-rating.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is currently trending as investors debate its long-term valuation and AI growth potential, with community discussion sharply divided between those viewing recent price dips as a buying opportunity and others expressing concern over high P/E ratios and potential semiconductor sector saturation. Sentiment is further fueled by ongoing technical analysis of its support levels, reactions to broader chip sector financing narratives, and active monitoring of institutional activity ahead of upcoming earnings.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

XRP is facing intense community debate and volatility as its price drops below the psychological one-dollar threshold, with investors split between buying the dip and fearing a continued slide. The conversation is heavily focused on uncertainty regarding upcoming regulatory clarity and skepticism over institutional adoption.

Netlist, Inc. engages in the design, manufacture and sale of memory subsystems for the computing and communications markets. Its products include enterprise SSD, embedded flash, memory module, lightning DDR5 DIMM, SK hynix, AI server. The company was founded by Jayesh Bhakta, Chun Ki Hong and Christopher Lopes in June 2000 and is headquartered in Irvine, CA.

Netlist Inc

Netlist is trending as a major breakout play driven by the recent landmark settlement with Samsung and a new ITC patent infringement complaint against Micron, fueling widespread community discussion about a potential short squeeze. Investors are increasingly optimistic about the company's valuation, citing a growing backlog of pending licensing agreements and a broader momentum shift in the semiconductor memory sector.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology is trending as investors weigh strong AI-driven revenue growth and aggressive regional infrastructure expansion against concerns regarding convertible debt and historical dilution. The community is focused on the upcoming earnings report, with many looking for a potential short squeeze fueled by significant short interest and anticipation that strong numbers will trigger a major revaluation.

iShares Trust - iShares Russell 2000 Index Fund

iShares Russell 2000 ETF

The IWM is trending as investors debate whether the ETF is reaching overextended levels at all-time highs or if small-cap momentum remains sustainable amid broader market rotations. Traders are actively monitoring potential resistance at recent highs while reacting to conflicting sentiment regarding interest rate policies and institutional positioning.

Unusual Machines, Inc. is a development stage technology company, which engages in the provision of drone solutions with a focus on first-person view (FPV) technology. It offers products to entertainment, recreation, and competitive racing industries. The company was founded on July 11, 2019, and is headquartered in Orlando, FL.

Unusual Machines Inc

Unusual Machines ($UMAC) is seeing heightened volatility and investor interest driven by a significant defense policy catalyst regarding new government tariffs on foreign-made drones, which is expected to favor domestic manufacturers. The community is heavily focused on the stock's short-squeeze potential and potential for long-term domestic supply chain growth, though some participants remain cautious due to ongoing share dilution concerns and the stock's high sensitivity to speculative news flow.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is seeing increased volatility as investors weigh the company's long-term potential against concerns over the expiration of government reimbursements and the need for greater clarity on revenue guidance. While the community remains divided over management's communication and recent leadership changes, many are actively monitoring for updates on product adoption, institutional ownership trends, and the status of ongoing clinical milestones.

EyePoint, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.

EyePoint Inc.

EyePoint Pharmaceuticals Inc

EyePoint Pharmaceuticals is seeing heavy trading activity as investors monitor the upcoming Phase 3 trial readouts for DURAVYU, with community sentiment split between excitement over potential durability advantages and caution regarding short interest and pending binary trial catalysts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

 Bet on 5 Top-Ranked Stocks With Rising P/E 

Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. 

Orthofix (OFIX) Q2 Earnings and Revenues Surpass Estimates

Orthofix (OFIX) delivered earnings and revenue surprises of +333.33% and +0.67%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Orthofix Reports Second Quarter 2026 Results Reflecting Continued Operational Progress

Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the second quarter ended June 30, 2026, reflecting progress toward a more focused and consistent operating model. The Company also raised its full-year 2026 guidance for both...

Did Orthofix Medical Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Did Orthofix Medical Inc. Insiders Breach their Fiduciary Duties to Shareholders? Did Orthofix Medical Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire NEW YORK, July 29, 2026 Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or...

Analysts Estimate Orthofix (OFIX) to Report a Decline in Earnings: What to Look Out for

Orthofix (OFIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Orthofix Medical (OFIX) Looks Attractive After CMS Reversed Its Reimbursement

Orthofix Medical (OFIX) Looks Attractive After CMS Reversed Its Reimbursement...

Wall Street Analysts Think Orthofix (OFIX) Could Surge 33.28%: Read This Before Placing a Bet

The average of price targets set by Wall Street analysts indicates a potential upside of 33.3% in Orthofix (OFIX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

MedTech Pioneer Max Reinhardt Joins eXeX to Drive Canopus Platform Growth

MedTech Pioneer Max Reinhardt Joins eXeX to Drive Canopus Platform Growth MedTech Pioneer Max Reinhardt Joins eXeX to Drive Canopus Platform Growth PR Newswire ORLANDO, Fla. and LONDON, July 21, 2026 The Johnson & Johnson, Pacira BioSciences and Orthofix executive takes charge of commercial...

Orthofix to Participate in Upcoming Investor Conferences

Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that Orthofix will participate in the following investor conferences: Needham Virtual MedTech & Diagnostics 1x1 Conference - Virtual, August 10, 2026, 1x1 Meetings Canaccord Genuitys 46th Annual Growth...

Orthofix to Report Second Quarter 2026 Financial Results

Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that it will release its second quarter 2026 financial results on Wednesday, August 5, 2026, before market open. The Company will host a conference call and webcast to review results at 8:30 am Eastern...

Orthofix Medical, Inc. develops and markets medical devices and biologic solutions for spine and orthopedic applications. The company operates through two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers two primary product categories: Bone Growth Therapies and Spinal Implants, Biologics, and Enabling Technologies. Bone Growth Therapies includes noninvasive stimulation devices used in spinal fusion and fracture-healing applications. Spinal Implants, Biologics, and Enabling Technologies includes a broad portfolio of spine fixation and motion-preservation products, biologic solutions, and image-guided surgical technologies used in spine procedures. The Global Limb Reconstruction segment provides products and solutions for limb reconstruction, deformity correction, fracture management, and other orthopedic conditions unrelated to the spine. The company was founded on October 19, 1987 and is headquartered in Lewisville, TX.

Orthofix Medical Inc

Neutral Sentiment

Up more than 1% 

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is headed towards a winning week. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Earnings

Fundamentals

Info